ClinicalTrials.gg

Drug class

Selective Serotonin Reuptake Inhibitors clinical trials

A class of medicines: the studies that test any of its 14 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
1,366
open now
105
in phase 3
321
first study started
1990

Keep track of what changes. Save the selective serotonin reuptake inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Studies by the year they started

1,340 studies that test it; most in 2008 (87); 1 more planned to start later

Studies that test Selective Serotonin Reuptake Inhibitors, by start year
YearStudies
19901
19922
19942
19953
19963
199710
199811
199910
200022
200137
200249
200365
200466
200576
200668
200749
200887
200960
201070
201150
201255
201342
201448
201539
201651
201742
201833
201946
202043
202139
202243
202322
202436
202534
202626

By phase

A phase 1/2 study counts in both.

Early Phase 1
18
Phase 1
195
Phase 2
259
Phase 3
321
Phase 4
428
No phase
212

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 365 · Other 1,001

Eli Lilly and Company (51) · H. Lundbeck A/S (41) · New York State Psychiatric Institute (36) · Massachusetts General Hospital (25) · Takeda (25) · GlaxoSmithKline (23) · Duke University (19) · University of Pittsburgh (18)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 1,366

See all 1,366 studies that test one of the selective serotonin reuptake inhibitors →

Codes

What other systems call Selective Serotonin Reuptake Inhibitors · ClinicalTrials.gg INT008597

  • MeSH (NLM) D017367Selective Serotonin Reuptake InhibitorsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.